BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19649983)

  • 1. Induced pluripotent stem cells: will they be safe?
    Jalving M; Schepers H
    Curr Opin Mol Ther; 2009 Aug; 11(4):383-93. PubMed ID: 19649983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of human induced pluripotent stem cells for research and therapy.
    Nishikawa S; Goldstein RA; Nierras CR
    Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced human pluripotent stem cells: promises and open questions.
    Rolletschek A; Wobus AM
    Biol Chem; 2009 Sep; 390(9):845-9. PubMed ID: 19558327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
    Eminli S; Utikal J; Arnold K; Jaenisch R; Hochedlinger K
    Stem Cells; 2008 Oct; 26(10):2467-74. PubMed ID: 18635867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activation of the reprogramming transcription factors.
    Guo J; Li ZC; Feng YH
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From fibroblasts to iPS cells: induced pluripotency by defined factors.
    Zhao R; Daley GQ
    J Cell Biochem; 2008 Nov; 105(4):949-55. PubMed ID: 18668528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
    Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
    J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: an advantageous alternative to ES and iPS cells.
    Amoh Y; Kanoh M; Niiyama S; Hamada Y; Kawahara K; Sato Y; Hoffman RM; Katsuoka K
    J Cell Biochem; 2009 Aug; 107(5):1016-20. PubMed ID: 19507228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of human induced pluripotent stem cells.
    Ohnuki M; Takahashi K; Yamanaka S
    Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotency of mouse and human somatic cells.
    Maherali N; Hochedlinger K
    Cold Spring Harb Symp Quant Biol; 2008; 73():157-62. PubMed ID: 19022751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse induced pluripotent stem cells.
    Geoghegan E; Byrnes L
    Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
    Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.